Effects of Exercise on Cardiac Function Outcomes in Women Receiving Anthracycline or Trastuzumab Treatment for Breast Cancer: A Systematic Review and Meta-Analysis
Source abstract
Abstract
Background: we conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to evaluate the efficacy of exercise training on cardiac function and circulating biomarkers outcomes among women with breast cancer (BC) receiving anthracycline or trastuzumab-containing therapy. Methods: PubMed, EMBASE, Cochrane Library, Web of Science and Scopus were searched. The primary outcome was change on left ventricular ejection fraction (LVEF). Secondary outcomes included diastolic function, strain imaging and circulating biomarkers. Results: Four RCTs were included, of those three were conducted during anthracycline and one during trastuzumab, involving 161 patients. All trials provided absolute change in LVEF (%) after a short to medium-term of treatment exposure (≤6 months). Pooled data revealed no differences in LVEF in the exercise group versus control [mean difference (MD): 2.07%; 95% CI: −0.17 to 4.34]. Similar results were observed by pooling data from the three RCTs conducted during anthracycline. Data from trials that implemented interventions with ≥36 exercise sessions (n = 3) showed a significant effect in preventing LVEF decline favoring the exercise (MD: 3.25%; 95% CI: 1.20 to 5.31). No significant changes were observed on secondary outcomes. Conclusions: exercise appears to have a beneficial effect in mitigating LVEF decline and this effect was significant for interventions with ≥36 exercise sessions.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Chemotherapy-induced cardiotoxicity and mitigation · Cancer Treatment and Pharmacology · Cardiovascular and exercise physiology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Research Center in Sport Sciences, Health and Human Development, CIDESD, University of Beira Interior, 6201-001 Covilhã, Portugal
Associação de Investigação de Cuidados de Suporte em Oncologia (AICSO), 4410-406 Vila Nova de Gaia, Portugal
Department of Mathematics and Center of Mathematics and Applications, University of Beira Interior, 6201-001 Covilhã, Portugal
Medical Oncology, Centro Hospitalar Vila Nova de Gaia/Espinho, 4400-129 Vila Nova de Gaia, Portugal
Faculty of Health Sciences, University of Beira Interior, 6201-001 Covilhã, Portugal
CIDMA—Center for Research and Development in Mathematics and Applications, University of Aveiro, 3810-193 Aveiro, Portugal
Psychiatry and Mental Health Department, Centro Hospitalar de Setúbal, 2190-446 Setúbal, Portugal
Research Center in Sports Sciences, Health Sciences and Human Development, CIDESD, University Institute of Maia—ISMAI, 4475-690 Maia, Portugal
Funding
Fundação para a Ciência e a Tecnologia
References (56)
Show source-provided references
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries10.3322/caac.21492 ↗
2. American Cancer Society (2020). Cancer Facts & Figures 2020, American Cancer Society.
3. American Cancer Society (2019). Cancer Treatment & Survivorship Facts & Figures 2019–2021, American Cancer Society.
4. Breast cancer survivorship: A comprehensive review of long-term medical issues and lifestyle recommendations10.7812/TPP/14-241 ↗
5. Cardiotoxicity of Contemporary Breast Cancer Treatments10.1007/s11864-019-0646-1 ↗
6. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer10.1001/jamacardio.2016.3841 ↗
7. Cardiovascular Disease Mortality Among Breast Cancer Survivors10.1097/EDE.0000000000000394 ↗
8. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline10.1200/JCO.2016.70.5400 ↗
9. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)10.1093/eurheartj/ehw211 ↗
10. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging10.1093/ehjci/jeu192 ↗
11. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab10.1161/CIRCIMAGING.112.973321 ↗
12. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)10.1093/eurheartj/ehw106 ↗
13. Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable10.1249/MSS.0000000000002116 ↗
14. A systematic review of the safety and efficacy of aerobic exercise during cytotoxic chemotherapy treatment10.1007/s00520-018-4295-x ↗
15. Exercise for women receiving adjuvant therapy for breast cancer
16. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer10.1200/JCO.2015.65.6603 ↗
17. Effect of Aerobic and Resistance Exercise Intervention on Cardiovascular Disease Risk in Women With Early-Stage Breast Cancer: A Randomized Clinical Trial10.1001/jamaoncol.2019.0038 ↗
18. Effects of physical exercise on outcomes of cardiac (dys)function in women with breast cancer undergoing anthracycline or trastuzumab treatment: Study protocol for a systematic review10.1186/s13643-019-1154-x ↗
19. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement10.1186/2046-4053-4-1 ↗
20. Higgins, J.P.T., and Green, S. (2011). Cochrane Handbook for Systematic Reviews of Interventions.Version 5.1.0 [Updated March 2011], The Cochrane Collaboration. Available online: www.cochranehandbook.org.
21. Measuring inconsistency in meta-analyses10.1136/bmj.327.7414.557 ↗
22. Borenstein, M., Hedges, L.V., Higgins, J.P., and Rothstein, H.R. (2009). Introduction to Meta-Analysis, John Wiley & Sons Inc.10.1002/9780470743386 ↗
23. Hojan, K., Procyk, D., Horyńska-Kęstowicz, D., Leporowska, E., and Litwiniuk, M. (2020). The Preventive role of Regular Physical Training in Ventricular Remodeling, Serum Cardiac Markers, and Exercise Performance Changes in Breast Cancer in Women Undergoing Trastuzumab Therapy-An REH-HER Study. J. Clin. Med., 9.10.3390/jcm9051379 ↗
24. Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: A phase II randomized trial10.3109/0284186X.2013.781673 ↗
25. The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: A RCT10.1007/s10549-017-4554-4 ↗
26. Effect of anthracycline combined with aerobic exercise on the treatment of breast cancer
27. (2020, May 24). ACTRN12617001408370. Exercise for Diagnosis and Treatment of Heart Dysfunction among Breast Cancer Patients. Available online: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373668(Date registered: 5 October 2017).
28. (2020, May 24). ISRCTN3261790. Effects of Physical Exercise on Cardiac Health in Women with Breast Cancer. Available online: http://www.isrctn.com/ISRCTN32617901(Date assigned: 24 October 2018).
29. (2020, May 24). NCT03131024. Caloric Restriction and Exercise for Protection From Anthracycline Toxic Effects (CREATE), Available online: https://clinicaltrials.gov/ct2/show/NCT03131024(First Posted: 27 April 2017).
30. (2020, May 24). NCT02454777. High-Intensity Interval Training for Stage I-III Breast Cancer Patients, Available online: https://clinicaltrials.gov/ct2/show/NCT02454777(First Posted: 27 May 2015).
31. (2020, May 24). NCT03027063. Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin among Women Newly Diagnosed With Breast Cancer, Available online: https://www.clinicaltrials.gov/ct2/show/NCT03027063(First Posted: 20 January 2017).
32. (2020, May 24). NCT03748550. Exercise to Prevent AnthraCycline-Based Cardio-Toxicity Study 2.0 (EXACT2) (EXACT 2), Available online: https://clinicaltrials.gov/ct2/show/NCT03748550(First Posted: 21 November 2018).
33. (2020, May 24). NCT01621659. Multidisciplinary Team IntervenTion in CArdio-ONcology (TITAN Study) (TITAN), Available online: https://clinicaltrials.gov/ct2/show/study/NCT01621659(First Posted: 18 June 2012).
34. (2020, May 24). NCT03850171. Cancer Adverse Effects PReventIon with Care & Exercise: The CAPRICE Study. (First Posted: 21 February 2019), Available online: https://clinicaltrials.gov/ct2/show/NCT03850171.
35. (2020, May 24). NCT03964142. Exercise-Based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced Cardiotoxicity (ONCORE), Available online: https://clinicaltrials.gov/ct2/show/NCT03964142(First Posted: 28 May 2019).
36. (2020, May 24). TCTR20190330002. The Exercise Effects on Cardiotoxicity in Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy. Available online: http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=4503(Date of Primary Registry: 30 March 2019).
37. Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: A study protocol for a randomized controlled trial10.1186/s13063-019-3499-9 ↗
38. Jacquinot, Q., Meneveau, N., Chatot, M., Bonnetain, F., Degano, B., Bouhaddi, M., Dumoulin, G., Vernerey, D., Pivot, X., and Mougin, F. (2017). A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: Design of the CARDAPAC study. BMC Cancer, 17.10.1186/s12885-017-3420-4 ↗
39. Kirkham, A.A., Paterson, D.I., Prado, C.M., Mackey, J.M., Courneya, K.S., Pituskin, E., and Thompson, R.B. (2018). Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: A 3-arm parallel group phase II randomized controlled trial in early breast cancer. BMC Cancer, 18.10.1186/s12885-018-4778-7 ↗
40. Pituskin, E., Haykowsky, M., McNeely, M., Mackey, J., Chua, N., and Paterson, I. (2016). Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN). BMC Cancer, 16.10.1186/s12885-016-2761-8 ↗
41. D’Ascenzi, F., Anselmi, F., Fiorentini, C., Mannucci, R., Bonifazi, M., and Mondillo, S. (2019). The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology. Eur. J. Prev. Cardiol., 2047487319874900.10.1177/2047487319874900 ↗
42. Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association10.1161/CIR.0000000000000679 ↗
43. Heart failure in chemotherapy-related cardiomyopathy: Can exercise make a difference?10.1016/j.bbacli.2016.06.001 ↗
44. Treatment-Induced Cardiotoxicity in Breast Cancer: A Review of the Interest of Practicing a Physical Activity10.1159/000499383 ↗
45. Exercise Prevention of Cardiovascular Disease in Breast Cancer Survivors10.1155/2015/917606 ↗
46. Aerobic exercise in anthracycline-induced cardiotoxicity: A systematic review of current evidence and future directions10.1152/ajpheart.00646.2016 ↗
47. Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis10.1200/JCO.2017.77.5809 ↗
48. Maginador, G., Lixandrão, M., Bortolozo, H., Vechin, F., Sarian, L., Derchain, S., Telles, G., Zopf, E., Ugrinowitsch, C., and Conceição, M. (2020). Aerobic exercise-induced changes in cardiorespiratory fitness in breast cancer patients receiving chemotherapy: A systematic review and meta-analysis. Cancers, 12.10.3390/cancers12082240 ↗
49. Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients10.1177/2047487318811181 ↗
50. Persistent Impairment in Cardiopulmonary Fitness after Breast Cancer Chemotherapy10.1249/MSS.0000000000001970 ↗
51. Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training10.1158/1078-0432.CCR-09-0628 ↗
52. Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast Cancer10.1001/jamacardio.2019.5586 ↗
53. Exercise Attenuates Cardiotoxicity of Anthracycline Chemotherapy Measured by Global Longitudinal Strain
54. Effects of exercise training on left ventricular remodelling in heart failure patients: An updated meta-analysis of randomised controlled trials10.1111/j.1742-1241.2012.02942.x ↗
55. The effect of resistance training on clinical outcomes in heart failure: A systematic review and meta-analysis10.1016/j.ijcard.2016.07.046 ↗
56. Meta-analysis of Exercise Training on Left Ventricular Ejection Fraction in Heart Failure with Reduced Ejection Fraction: A 10-year Update10.1016/j.pcad.2018.08.006 ↗